| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/26/1997 | CN1145789A Non-toxic sedative anticancer Chinese medicine capsule |
| 03/26/1997 | CN1145785A Medicine for treatment of malignant tumour and its prepn |
| 03/25/1997 | US5614645 Methods for making 2-debenzoyl and -2-acyl taxol derivatives |
| 03/25/1997 | US5614628 Antitumor |
| 03/25/1997 | US5614625 Collagenase inhibitors |
| 03/25/1997 | US5614621 Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents |
| 03/25/1997 | US5614618 Origin of replication complex genes |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614610 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614535 Adhesion receptor antagonists |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614185 Compositions containing reduced, microbially produced interleukin-2 (IL-2) |
| 03/25/1997 | CA2067178C Solid tumor treatment method and composition |
| 03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
| 03/25/1997 | CA1339007C Collagen wound healing matrices and process for their production |
| 03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010269A1 Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof |
| 03/20/1997 | WO1997010263A1 Actinomycin d analogues |
| 03/20/1997 | WO1997010245A1 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT |
| 03/20/1997 | WO1997010234A1 Hydrolysis-promoting taxane hydrophobic derivatives |
| 03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 03/20/1997 | WO1997010002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997010000A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009987A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 03/20/1997 | WO1997009975A1 Topical anti-skin-cancer preparations |
| 03/20/1997 | WO1997009968A1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/20/1997 | WO1997009889A1 Cancer chemoprotective food products |
| 03/20/1997 | CA2368867A1 Cancer chemoprotective food products |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231998A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763537A2 Non-peptidyl Ras farnesyl transferase inhibitors |
| 03/19/1997 | EP0763124A1 Method for introducing nucleic acid in higher eukaryotic cells |
| 03/19/1997 | EP0763121A1 Method of cancer treatment by p53 protein control |
| 03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 03/19/1997 | EP0763049A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0763042A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents |
| 03/19/1997 | EP0763041A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents |
| 03/19/1997 | EP0763040A1 Carbazole derivatives as agents against multi-drug resistance |
| 03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763026A1 Gastrin and cck antagonists |
| 03/19/1997 | EP0763013A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents |
| 03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
| 03/19/1997 | EP0762882A1 Vitronectin receptor antagonists |
| 03/19/1997 | EP0762879A1 Stereochemical wortmannin derivatives |
| 03/19/1997 | EP0754302A4 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | EP0644872B1 Ornithine decarboxylase inhibiting cyclic aminooxy compounds |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | CN1145638A Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145624A Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 03/19/1997 | CN1145622A 06-substituted guanine derivatives, a process for their prepn. and their use |
| 03/19/1997 | CN1145620A New piperazine derivatives and its prepn. |
| 03/19/1997 | CN1145365A Camptothecin derivatives |
| 03/19/1997 | CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 03/18/1997 | US5612367 Method of enhancing bioavailability of pharmaceutical agents |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612356 Retinoid antagonists |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612318 Control of gene expression by ionizing radiation |
| 03/18/1997 | US5612313 Controlled-pH formulation for intravesicular instillation of TGFαPE40 ab |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies |
| 03/18/1997 | US5612016 Conjugates of antibodies and bifunctional ligands |
| 03/18/1997 | CA2087600C Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof |
| 03/13/1997 | WO1997009440A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/13/1997 | WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | WO1997009348A2 Orphan receptor |
| 03/13/1997 | WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | WO1997009298A1 Production of an immunosuppressant using microorganisms |
| 03/13/1997 | WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | WO1997009045A1 Use of a carbostyril derivative for inhibiting carcinogenesis |
| 03/13/1997 | WO1997009043A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |
| 03/13/1997 | DE19533330A1 Gegen Hautkrebs wirksame topische Zubereitungen Against skin cancer effective topical preparations |
| 03/13/1997 | CA2231182A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | CA2231114A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | CA2228898A1 An agent for inhibiting carcinogenesis |
| 03/13/1997 | CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/12/1997 | EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces |
| 03/12/1997 | EP0761684A2 Alanine substitution analogues of magainin peptides |